Scientific
publications
2022
Further prospective systematic observations from an exploratory study in patients with neuropathic cancer pain.
2013
Perfect alignment: A series of circumstances, vigilance, clinical acumen, and serendipity.
2013
Second case series: Confirmation of hypothesis.
2012
Hypothesis: Reduction in neuropathic pain through EGFR-inhibition.
Further proof of concept
from external groups
2022
Screening method 1 identifying EGFR as target against neuropathic pain.
2022
1st case series from a different group reporting pain relief after treatment with the mAb panitumumab.
2021
Screening method 2 identifying EGFR as target against neuropathic pain.
2020
The EGFR's potential role in opioid tolerance is first introduced.
2019
EGFR-ligand is released from intervertebral disks and induces spontaneous activity in pain pathways.
2017